-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Overweight on Definitive Healthcare, Lowers Price Target to $18

Benzinga · 01/06/2023 09:15
Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Overweight and lowers the price target from $21 to $18.